arrow
L

Louise Carter

the christie hospital nhs foundation trust
H指数:20
被引数:3,372

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

UpSMART: five years of digital innovation in cancer clinical research—achievements; challenges; and recommendations

UpSMART:癌症临床研究领域五年数字创新——成就、挑战与建议

2025-11-280
OAAI
NEXUS-01, a phase 1 study of LY4052031, an antibody-drug conjugate targeting Nectin-4 in participants with advanced or metastatic urothelial carcinoma or other solid tumors (Trial in Progress)
2024-10-010
PRE
BT8009 monotherapy in enfortumab vedotin (EV)-naive patients (pts) with metastatic urothelial carcinoma (mUC): Updated results of Duravelo-1

BT8009单药治疗在enfotumab vedotin(EV)初治患者(pts)中的转移性尿路上皮癌(mUC):Duravelo-1研究的更新结果

2024-09-012
PRE
Ataxia telangiectasia and Rad3-related (ATR) inhibitor camonsertib dose optimization in patients with biomarker-selected advanced solid tumors (TRESR study)
2024-05-062
OAAI
Phase 1b trial Mipasetamab Uzoptirine (ADCT-601-102) dose escalation in patients with advanced bone and soft tissue sarcomas
2024-04-050
PRE
Trial in progress: First-in-human phase I dose-escalation study of a novel Bicycle toxin conjugate (BT5528) targeting EphA2 in patients with advanced solid tumors
2023-12-010
PRE
DETERMINE: A pioneering UK precision medicine trial for rare cancers

确定: 英国针对罕见癌症的开创性精密医学试验

2023-10-010
PRE
Camonsertib in DNA damage response-deficient advanced solid tumors: phase 1 trial results
2023-06-0530
OAAI